Related Experiment Video
Updated: Jun 15, 2026

09:32
Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
[Pathological prognostic indicators in renal cell carcinoma].
J Rey Rey1, D León Ramírez, S López García
1Servicio de Urología, Complejo Hospitalario Universitario de Vigo, Vigo, Pontevedra, España. jorge292@gmail.com
Actas Urologicas Espanolas
|March 13, 2010
Summary
Fuhrman grade and pT stage are key prognostic factors for renal cell carcinoma survival. Other histological factors like tumor necrosis and vascular invasion also impact patient outcomes.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Context:
- Renal cell carcinoma (RCC) prognosis traditionally relies on TNM staging, Fuhrman grade, and tumor size.
- Histological factors like tumor necrosis, microscopic vascular invasion, and sinus fat invasion are not routinely assessed.
- Understanding these factors can refine prognostic accuracy for localized RCC.
Purpose:
- To evaluate the prognostic significance of non-traditional histological factors in localized renal cell carcinoma.
- To compare the impact of tumor necrosis, vascular invasion, and sinus fat invasion against established prognostic indicators.
- To determine the most influential factors for cancer-specific and disease-free survival in RCC patients.
Summary:
- A retrospective analysis of 139 localized RCC patients undergoing nephrectomy was performed.
- Univariate analysis showed all assessed variables significantly influenced RCC mortality.
- Multivariate analysis identified Fuhrman grade as the strongest predictor of survival, while pT stage and Fuhrman grade significantly impacted disease-free survival.
Impact:
- Fuhrman grade and pT stage are confirmed as critical prognostic factors for localized RCC survival and disease-free survival.
- Tumor necrosis, microscopic vascular invasion, and sinus fat invasion are identified as significant prognostic indicators for RCC-related death.
- These findings can potentially enhance risk stratification and treatment planning for renal cell carcinoma patients.